Developer docs
API playgroundTry for free, no card

Search company profiles

Cohera Medical

Full company profile

uuid0004hk5

Namestring
Cohera Medical
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Cohera Medical is a privately held medical device company founded in 2006 and headquartered in Pittsburgh, Pennsylvania. The company develops surgical adhesives and sealants designed for application and use in surgical procedures, addressing tissue closure, leak prevention, and wound-sealing needs across surgical specialties. Its product focus sits within the broader surgical sealants and tissue patches market where it competes against larger medtech players such as Johnson & Johnson and Medtronic as well as specialty peers. The company operates with a lean headcount of 11–50 employees and is led scientifically by Chief Scientific Officer Dottie Clower.

Over its operating history, Cohera Medical has raised approximately $135 million across eight discrete financing rounds between 2006 and 2015, with the largest single event being a $50 million Series 4 led by Kohlberg Kravis Roberts & Co. in October 2015. Bradford Capital Partners and Kern Whelan Capital participated in earlier Series 2 financing in 2008. No publicly disclosed revenue, customer base, pricing model, or commercial channel structure is available in the provided sources, and the firm's own website content was not accessible during data collection.

The business model is consistent with a Class III surgical device company: revenue is generated through sales of proprietary, regulatory-cleared adhesive and sealant products to hospitals and surgical centers, typically via specialty surgical distributors or direct sales force. The absence of any disclosed funding event, product launch, partnership, or leadership change since October 2015 — combined with no documented customer logos, partnerships, distribution agreements, or geographic expansion — is itself a material signal that warrants diligence on the company's current commercial velocity, product lifecycle status, and runway sufficiency.

Short descriptiontext

Cohera Medical is a Pittsburgh-based medical device company that develops surgical adhesives and sealants for use in surgical procedures, serving hospitals and surgical centers with proprietary tissue-closure products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPittsburgh, United States
HQ citystring
Pittsburgh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
surgical adhesives, tissue sealants, medical device manufacturing, surgical wound closure, biocompatible adhesives
Industry2 codes
1Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips)
CodeHLAHALADPrimaryYes
2Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
CodeHLAAAGAGPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Surgical Adhesives and Sealants
No data
Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cohera Medical develops surgical adhesives and sealants for use in surgical procedures. The company manufactures tissue-adhesive products designed for application during surgery to support wound closure and sealing. It operates as a medical device manufacturer selling proprietary surgical adhesive products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No specific product information for Cohera Medical is available in the provided source data. The news sources discuss the broader surgical sealants and tissue patches market, mentioning competitors like Johnson & Johnson, Medtronic, H.B. Fuller, and Animus Surgical, but no Cohera Medical products are detailed.

Product and service1 record
1Surgical adhesives and sealants
CategorySurgical adhesives and sealants
Description

Proprietary surgical adhesive and sealant products designed for application during surgical procedures to support tissue sealing and wound closure. Targeted at hospitals, ambulatory surgery centers, and surgeons performing procedures that require tissue-adhesive closure.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Emerging surgical adhesives/sealants developer named alongside Cohera in the source data. Comparable as a smaller, niche participant in the same surgical sealants and tissue patches market.

TypeBroad incumbent
Description

Large MedTech incumbent with a broad surgical and hemostasis portfolio including sealants and tissue adhesives (e.g., Tisseel, Floseal), competing with Cohera in the OR setting across multiple surgical specialties.

TypeDirect peer
Description

Surgical adhesives and sealants specialist (formerly CryoLife) selling BioGlue and other tissue adhesives for cardiac, vascular, and general surgery. Closely comparable specialty adhesive business competing in the same surgeon call point as Cohera.

TypeBroad incumbent
Description

Ethicon, J&J's surgical solutions division, offers tissue adhesives, sealants, and hemostats and is explicitly named as a competitor in the source data. Comparable because it sells surgical sealants used in the same OR use cases as Cohera's products.

TypeBroad incumbent
Description

Global MedTech with a surgery and biosurgery portfolio that includes sealants and hemostats. Comparable because it competes in the OR tissue sealing category that Cohera addresses, while operating as a much larger diversified player.

TypeBroad incumbent
Description

Specialty MedTech company with tissue adhesives, dural sealants, and regenerative wound care products. Comparable because it serves overlapping surgical specialties with adhesive and sealant solutions used to close or seal tissue.

TypeDirect peer
Description

UK-listed MedTech focused on wound closure, surgical sealants, and tissue adhesives (e.g., LiquiBand). Comparable because it commercializes surgical tissue adhesives and sealants used in OR settings, overlapping directly with Cohera's product category.

TypeDirect peer
Description

German specialty MedTech developing cyanoacrylate-based topical and surgical tissue adhesives. Comparable as a smaller, science-driven adhesive developer competing in similar clinical use cases for tissue closure and sealing.

TypeDirect peer
Description

UK-based surgical sealant company focused on tissue sealant films and patches used across multiple surgical indications. Comparable as a focused, indication-overlapping competitor in surgical tissue sealing.

TypeBroad incumbent
Description

Diversified MedTech leader named as a competitor in the surgical sealants market. Comparable via its surgical and perioperative portfolio that includes products competing in tissue sealing and reinforcement use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cohera Medical

Surgical Adhesives and Sealantscoheramedical.com

Cohera Medical is a Pittsburgh-based medical device company that develops surgical adhesives and sealants for use in surgical procedures, serving hospitals and surgical centers with proprietary tissue-closure products.

What Cohera Medical does

Cohera Medical is a privately held medical device company founded in 2006 and headquartered in Pittsburgh, Pennsylvania. The company develops surgical adhesives and sealants designed for application and use in surgical procedures, addressing tissue closure, leak prevention, and wound-sealing needs across surgical specialties. Its product focus sits within the broader surgical sealants and tissue patches market where it competes against larger medtech players such as Johnson & Johnson and Medtronic as well as specialty peers. The company operates with a lean headcount of 11–50 employees and is led scientifically by Chief Scientific Officer Dottie Clower.

Over its operating history, Cohera Medical has raised approximately $135 million across eight discrete financing rounds between 2006 and 2015, with the largest single event being a $50 million Series 4 led by Kohlberg Kravis Roberts & Co. in October 2015. Bradford Capital Partners and Kern Whelan Capital participated in earlier Series 2 financing in 2008. No publicly disclosed revenue, customer base, pricing model, or commercial channel structure is available in the provided sources, and the firm's own website content was not accessible during data collection.

The business model is consistent with a Class III surgical device company: revenue is generated through sales of proprietary, regulatory-cleared adhesive and sealant products to hospitals and surgical centers, typically via specialty surgical distributors or direct sales force. The absence of any disclosed funding event, product launch, partnership, or leadership change since October 2015 — combined with no documented customer logos, partnerships, distribution agreements, or geographic expansion — is itself a material signal that warrants diligence on the company's current commercial velocity, product lifecycle status, and runway sufficiency.

Cohera Medical firmographics

Firmographics
Name
Cohera Medical
Website
https://coheramedical.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Cohera Medical is a Pittsburgh-based medical device company that develops surgical adhesives and sealants for use in surgical procedures, serving hospitals and surgical centers with proprietary tissue-closure products.
Ownership category
akta.pro rank

Cohera Medical industry classification

Industry
Product category
Surgical Adhesives and Sealants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD)
akta.pro secondary industry
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

  • Surgical adhesives
  • Tissue sealants
  • Medical device manufacturing
  • Surgical wound closure
  • Biocompatible adhesives

Where Cohera Medical is headquartered

Location

Headquarters

HQ city
Pittsburgh
HQ country
United States
HQ region
North America

Markets served

Cohera Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Cohera Medical product offering

Product offering

Core offering

Cohera Medical develops surgical adhesives and sealants for use in surgical procedures. The company manufactures tissue-adhesive products designed for application during surgery to support wound closure and sealing. It operates as a medical device manufacturer selling proprietary surgical adhesive products.

Product overview

No specific product information for Cohera Medical is available in the provided source data. The news sources discuss the broader surgical sealants and tissue patches market, mentioning competitors like Johnson & Johnson, Medtronic, H.B. Fuller, and Animus Surgical, but no Cohera Medical products are detailed.

Differentiator

Problem solved

Functional benefit

Products and services

  • Surgical adhesives and sealants Proprietary surgical adhesive and sealant products designed for application during surgical procedures to support tissue sealing and wound closure. Targeted at hospitals, ambulatory surgery centers, and surgeons performing procedures that require tissue-adhesive closure.

Companies that use Cohera Medical

Customer profile

Ideal customer profiles1 record

Cohera Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cohera Medical partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Cohera Medical competitors and assessment

Company assessment

Emerging players

  • Animus Surgical: Emerging surgical adhesives/sealants developer named alongside Cohera in the source data. Comparable as a smaller, niche participant in the same surgical sealants and tissue patches market.

Broad incumbents

  • Baxter International: Large MedTech incumbent with a broad surgical and hemostasis portfolio including sealants and tissue adhesives (e.g., Tisseel, Floseal), competing with Cohera in the OR setting across multiple surgical specialties.
  • Johnson & Johnson (Ethicon): Ethicon, J&J's surgical solutions division, offers tissue adhesives, sealants, and hemostats and is explicitly named as a competitor in the source data. Comparable because it sells surgical sealants used in the same OR use cases as Cohera's products.
  • BD (Becton Dickinson): Global MedTech with a surgery and biosurgery portfolio that includes sealants and hemostats. Comparable because it competes in the OR tissue sealing category that Cohera addresses, while operating as a much larger diversified player.
  • Integra LifeSciences: Specialty MedTech company with tissue adhesives, dural sealants, and regenerative wound care products. Comparable because it serves overlapping surgical specialties with adhesive and sealant solutions used to close or seal tissue.
  • Medtronic: Diversified MedTech leader named as a competitor in the surgical sealants market. Comparable via its surgical and perioperative portfolio that includes products competing in tissue sealing and reinforcement use cases.

Direct peers

  • Artivion: Surgical adhesives and sealants specialist (formerly CryoLife) selling BioGlue and other tissue adhesives for cardiac, vascular, and general surgery. Closely comparable specialty adhesive business competing in the same surgeon call point as Cohera.
  • Advanced Medical Solutions Group: UK-listed MedTech focused on wound closure, surgical sealants, and tissue adhesives (e.g., LiquiBand). Comparable because it commercializes surgical tissue adhesives and sealants used in OR settings, overlapping directly with Cohera's product category.
  • Adhesys Medical: German specialty MedTech developing cyanoacrylate-based topical and surgical tissue adhesives. Comparable as a smaller, science-driven adhesive developer competing in similar clinical use cases for tissue closure and sealing.
  • Tissuemed: UK-based surgical sealant company focused on tissue sealant films and patches used across multiple surgical indications. Comparable as a focused, indication-overlapping competitor in surgical tissue sealing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Cohera Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cohera Medical leadership team

Management profile

Number of profiles

Profiles1 record

Cohera Medical funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cohera Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cohera Medical

What does Cohera Medical do?

Cohera Medical develops surgical adhesives and sealants for use in surgical procedures. The company manufactures tissue-adhesive products designed for application during surgery to support wound closure and sealing. It operates as a medical device manufacturer selling proprietary surgical adhesive products.

When was Cohera Medical founded?

Cohera Medical was founded in 2006. It employs 11 to 50 people.

Where is Cohera Medical based?

Cohera Medical is headquartered in Pittsburgh, United States, in the North America region.

Who are Cohera Medical's main competitors?

Animus Surgical is listed as an emerging player. Broad incumbents are Baxter International, Johnson & Johnson (Ethicon), BD (Becton Dickinson), Integra LifeSciences and Medtronic. Direct peers are Artivion, Advanced Medical Solutions Group, Adhesys Medical and Tissuemed.

Does Cohera Medical have an API?

No public API is recorded for Cohera Medical.

What industry is Cohera Medical in?

Cohera Medical's product category is Surgical Adhesives and Sealants. Its primary akta.pro industry code is HLAHALAD, Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireCohera Medical, Inc.® Selected as Finalist for the 2017 NC Tech AwardsCohera Medical, a medical device company, was named a finalist for the NC Tech Awards Innovative Product award. Its products include TissuGlu Surgical Adhesive, approved in the U.S. and EU, and Sylys Surgical Sealant, under clinical investigation. The awards gala is set for November 9, 2017.Mpo-magCohera Medical Announces Exclusive Distribution Agreement for Cohera’s Sylys Surgical SealantCohera Medical signed an exclusive distribution agreement with Terumo Corporation for Sylys Surgical Sealant in Japan. The sealant is designed to reduce anastomotic leaks in colorectal surgery, where leaks occur in up to 23% of patients. Terumo will market the product for current and future indications, with regulatory approval in Japan planned.GlobeNewswireCohera Medical, Inc.® Appoints Paul Thomas to its Board ofCohera Medical appointed Paul Thomas to its Board of Directors on July 25, 2016. Thomas, CEO of Roka Bioscience, brings experience from LifeCell and Ohmeda. The appointment supports Cohera's U.S. launch of TissuGlu and clinical trials for Sylys.PR NewswireGlobal Medical Adhesives and Sealant IndustryThis July 2016 industry report analyzes the global medical adhesives and sealants market from 2015 through 2022, covering product segments including synthetic adhesives (acrylic, cyanoacrylate, silicone) and natural adhesives (albumin, collagen, fibrin), with applications in dental and medical fields. The report provides market data and forecasts for eight geographic regions, identifies key industry drivers such as aging populations and increasing surgical procedures, and profiles 63 companies operating in this sector. Notable corporate activities documented include Cohera Medical's FDA approval for TissuGlu and $50 million funding round, LifeBond's $27 million funding, and several acquisitions including Integra LifeSciences' purchase of the DuraSeal product series and DENTSPLY's merger with Sirona Dental Systems.FinSMEsCohera Medical Raises $50M in FundingCohera Medical closed a $50M equity financing round led by KKR, with Ali Satvat joining the board. The funds will launch U.S. commercial sales of TissuGlu, an FDA-approved surgical adhesive, and advance clinical trials for Sylys, a sealant under development for bowel repair.VC News DailyCohera Medical Grabs $50MCohera Medical announced closing the first tranche of a $50 million equity financing led by KKR, with participation from existing private investors. The company will use the funds to launch U.S. commercial sales of FDA-approved TissuGlu Surgical Adhesive and advance clinical trials for Sylys Surgical Sealant. As part of the transaction, KKR's Ali Satvat will join Cohera Medical's Board of Directors.FinSMEsCohera Medical Closes $26.3M Series D FinancingCohera Medical closed $9.3M in Series D financing, bringing total funding to $26.3M. The company will use the funds to pursue U.S. regulatory approval for its TissuGlu adhesive and CE Marking for its Sylys sealant. It has already received CE Marking for TissuGlu and submitted the final FDA module.VC News DailyCohera Medical Raises $17M in Series DCohera Medical secured $17 million in Series D financing to expand its surgical adhesive products in European markets and support clinical trials in the United States and Europe. The funds will specifically support the first No-Drain Clinical Study for TissuGlu in the U.S. and human clinical trials for its Sylys Surgical Sealant targeting colorectal procedures.VC News DailyCohera Medical Inks $25M Series CCohera Medical secured over $25 million in Series C financing from private investors, with $16.5 million from existing investors and over $9 million from new investors. The company will use the funds to expand adoption of TissuGlu in Germany and additional European markets while supporting US clinical trials for FDA approval. TissuGlu is an internal surgical adhesive for large flap surgeries that reduces fluid accumulation and post-surgical drain needs, and has already been used in over 160 procedures in Germany since its September 2011 launch.